Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NME2 pseudogene 2 (NME2P2) is a genetic element classified as a pseudogene, related by sequence similarity to the NME2 (NME/NM23 nucleoside diphosphate kinase 2) gene which encodes a functional enzyme involved in nucleotide metabolism, DNA-binding, and metastasis suppression. However, unlike NME2, NME2P2 is not known to encode a protein or have a direct biological or disease-related role. There is currently no evidence that NME2P2 functions as a druggable target, nor is it recognized in literature or major databases as having regulatory or biomarker utility. Its main importance is in genomic and evolutionary contexts. Note: - If your intent was to refer to the *functional* gene **NME2** (NM23B, nucleoside diphosphate kinase B), it would be a genuine enzyme with important biological and disease roles[1][2][3][4]. - **NME2P2** is distinct from **NME2**, being a non-functional, non-targetable pseudogene. - There is no evidence supporting a role for NME2P2 in drug response, disease, or molecular targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NME2 pseudogene 2 (NME2P2).